End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
Apr. 23 | PainChek Secures AU$1,210,000 R&D Tax Incentive | MT |
Mar. 14 | PainChek Establishes Reseller Agreement with UK-Based Nourish Care; Shares Rise 3% | MT |
Sales 2022 | 994K 650K | Sales 2023 | 1.96M 1.28M | Capitalization | 32.45M 21.22M |
---|---|---|---|---|---|
Net income 2022 | -5M -3.27M | Net income 2023 | -7M -4.58M | EV / Sales 2022 | 28.7 x |
Net cash position 2022 | 6.14M 4.02M | Net cash position 2023 | 2.51M 1.64M | EV / Sales 2023 | 15.3 x |
P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-4.26
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.56% |
Managers | Title | Age | Since |
---|---|---|---|
Philip Daffas
CEO | Chief Executive Officer | - | 16-09-29 |
Iain McAdam
DFI | Director of Finance/CFO | - | 21-03-21 |
Andrew Hoggan
COO | Chief Operating Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Murray
CHM | Chairman | 65 | 16-09-29 |
Ross Harricks
BRD | Director/Board Member | 79 | 16-09-29 |
Adam Davey
BRD | Director/Board Member | - | 14-09-29 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.98% | 316B | |
+25.06% | 212B | |
+3.81% | 147B | |
+11.25% | 56.54B | |
+10.40% | 32.23B | |
-1.25% | 29.66B | |
+102.62% | 21.88B | |
+20.22% | 19.71B | |
+0.17% | 14.5B |
- Stock Market
- Equities
- PCK Stock
- PCK Stock